Atlas Trials

Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties

Clinical trial NCT00932581 · COMPLETED

Trial details

NCT number
NCT00932581
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Parkinson's Disease
Start date
2009-06-01
Primary completion
2009-11-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.